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Background: To investigate the efficacy of the sole core decompression surgery for the treatment of
steroid-induced femoral head osteonecrosis.
Methods: The model was established by administration of steroids in combination with horse serum. The rabbits
with bilateral femoral head osteonecrosis were randomly selected to do the one side of core decompression.
The other side was used as the sham. Quantitative RT-PCR and western blot techniques were used to measure
the local expression of BMP-2 and PPAR-γ. Bone tissues from control and operation groups were histologically
analyzed by H&E staining. The comparisons of the local expression of BMP-2 and PPAR-γ and the bone
regeneration were further analyzed between different groups at each time point.
Results: The expression of BMP-2 in the osteonecrosis femoral head with or without decompression was
significantly lower than that in normal animals. BMP-2 expression both showed the decreasing trend with the
increased post-operation time. No significant difference of BMP-2 expression occurred between femoral head
osteonecrosis with and without decompression. The PPAR-γ expression in the femoral head osteonecrosis with and
without core decompression both was significantly higher than that in control. Its expression pattern showed a
significantly increased trend with increased the post-operation time. However, there was no significant difference of
PPAR-γ expression between the femoral head osteonecrosis with and without decompression at each time point.
Histopathological analysis revealed that new trabecular bone and a large number of osteoblasts were observed in
the steroid-induced femoral head osteonecrosis with lateral decompression at 8 weeks after surgery, but there
still existed trabecular bone fractures and bone necrosis.
Conclusions: Although decompression takes partial effect in promoting bone regeneration in the early treatment
of femoral head osteonecrosis, such an effect does not significantly improve or reverse the pathological changes of
femoral head necrosis. Thus, the long-term effect of core decompression in the treatment of steroid-induced
femoral head osteonecrosis is not satisfactory.
Keywords: Steroid-induced osteonecrosis, Core decompression, BMP-2, PPAR-γ* Correspondence: deiwei008@yahoo.com.cn
1Department of Orthopaedics, Second Affiliated Hospital, Xi’an Jiaotong
University School of Medicine, Xi’an, Shaanxi 710004, People's Republic of
China
Full list of author information is available at the end of the article
© 2012 Wang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Wang et al. BMC Musculoskeletal Disorders 2012, 13:142 Page 2 of 9
http://www.biomedcentral.com/1471-2474/13/142Background
Osteonecrosis of the femoral head (ONFH) is a relatively
common disease. Tow etiologic factors of this disease
are idiopathic and secondary to an underlying systemic
disease such as trauma, steroid intake, excessive alcohol
use, systemic lupus erythematosus, hemoglobinopathies
and dysbarism. Since most of the patients are young
individuals, huge social and family burden will come
[1] and a consider able number of these patients will
need revision surgeries in future. Once osteonecrosis
begins, 80 % of the femoral heads will collapse, if no
treatment. Glucocorticoids those are commonly pre-
scribed to patients with systemic lupus erythematosus,
nephrotic syndrome, and renal transplantation [2], or
autoimmune inflammatory diseases, neoplastic diseases
organ transplantation have been a leading cause of non-
traumatic femoral head osteonecrosis (FHON) [3].
Since the pathogenesis and aetiology of nontraumatic
osteonecrosis of the femoral head (ONFH) has not
been revealed completely, current treatment of ONFH
simply focuses on preventing irreversible complications,
namely, biomechanical collapse of the femoral head and
osteoarthritis of the hip joint . For the early treatment of
osteonecrosis, core decompression is generally consid-
ered to slow the natural process of osteonecrosis [4].
Nevertheless its efficacy still remains controversial.
Many studies showed that core decompression was per-
formed in the early stage in many cases failed to prevent
the progressive collapse. Meanwhile studies displayed
that the effect of the core decompression surgery for the
treatment of steroid-associated osteonecrosis of femoral
head (GONFH) in the severe bone necrosis was not as
good as that in the treatment of femoral head osteo-
necrosis caused by other risk factors.
In steroid-induced ONFH, the Increase of intraosseous
pressure due to the elevating of adipogenesis and fat cell
hypertrophy in the bone marrow. Although, conven-
tional core decompression also achieves reduction of
intra-medullary pressure and provided some pain relief
to some extent. It is unable to restrict bone marrow adi-
pogenesis and fat cell hypertrophy, so its efficacy for pre-
vention of steroid-induced ONFH is not ideal.
Recently innovative therapeutic approaches such as
the application of mesenchymal and bone marrow
mononuclear stem cells (MSCs or BMCs) [5-8], endo-
thelial progenitor cell (EPC)combined [9]. or growth fac-
tors (for example bone morphogenetic proteins) with
the classical decompression surgery. Other surgical strat-
egies include bone grafting (autologous bone grafts from
iliac crest or tibia, allograft cancellous grafts, non-
vascularized cortical grafts [10], or tantalum implants
[11]), or intertrochanteric de-rotating or Xexion/extension
osteotomies. None of these surgical options was found
to be superior to any other treatment. All these noveltreatment protocols emphasize seed cells, or scaffolds for
biomechanics, but ignore the effection of various intra-
corporal environment. To date, the best approach for
precollapse steroid-induced ONFH remains unknown.
The current study aimed to evaluate the influence
of the core decompression surgery in local marrow
cell metabolism and bone regeneration and reconstruc-
tion in the steroid-associated femoral head osteone-
crosis, and further explored the effects of core
decompression surgery alone on the early treatment of
steroid-induced osteonecrosis.
Methods
Animal, treatment and grouping
Forty six New Zealand healthy adult white rabbits
were purchased from Laboratory Animal Center at Xi'an
Jiaotong University, and were housed in according to the
guidelines for the care and the use of laboratory animals
delivered by the Science and Technology Committee of
Xian Jaotong University. Half animals were male and
other half were female, weighing from 2.6 to 3.2 kilo-
grams (an average of 2.9 kilograms). After one week
feeding adaptation, the animals were accurately weighed
and randomly divided into normal control group (6 cases)
and the experimental group (40 animals). There were
no statistically significant differences of the animal weight
and other clinical features such as gender between the
two groups (p > 0.05).
The establishment of the steroid-induced femoral head
osteonecrosis rabbit model
The rabbit steroid-induced femoral head osteonecrosis
model was established by the administration of steroid
in combination of horse serum. Briefly, the rabbits in
the experimental group were first given first injection of
10 ml/kg of horse serum (Beijing Yuan Heng Shengma
Bio Institute of Technology) intravenously. After interval
of 3 weeks, the second injection of horse serum was
repeated, and its dose was reduced to 6 ml/kg. Two
weeks after this, the animals were given an intraperito-
neal injection of methylprednisolone at 45 mg/kg (Pfizer,
USA) for consecutive three days. Starting from the
day of hormone injection, each animal was also intra-
peritoneally injected with penicillin 10 million units per
day for consecutive 7 days to prevent the animals
from infection. The six rabbits that were injected with
saline without receiving steroids were served as
normal controls.
MRI screening for osteonecrosis
In the two weeks after the last injection of hormones,
the two sides of hips of all survived experimental
animals were scanned with MRI. The both marrow
of femoral head exhibited fat appearance such as high
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T1W2/SPIR (T2WI pressure fat), which was identified
as potential femoral head osteonecrosis. The animals
with these signals were recruited into the experimental
group. Rabbits with bilateral normal femoral head
marrow were classified into the normal control group.
The rabbits with only one side of abnormal femoral head
were removed from the study.
Core decompression surgery and collection of bone
tissue samples
The animals selected for the core decompression surgery
were first weighed, and then anesthetized with a com-
bination of valium with ketamine (15 minutes after
intramuscular injection of 3.5 mg/kg of valium, ketamine
was intramuscularly injected at 25 mg/kg). After
anesthesia, a sterile needle for anesthesia was inserted
from the flare of the greater trochanter into the femoral
neck and head until about 2 mm under the greater
trochanter, following the femoral shaft axis at about
45°-55° angle. The inserted needle length was not more
than 2.5 cm inside the femoral marrow cavity. After suc-
cessful puncture, the anesthesia needle was removed.
Post-operative animals were intraperitoneally injected
with 80 million units of penicillin per day for continuous
three days just to prevent infection.
Tissue samples were collected at 2, 4, 8 weeks post-
operation from 2 normal control animals and 5 ran-
domly chosen surgical animals per each time point. The
same anesthetic method as above was used for the speci-
men collection. Then bilateral femoral heads were
quickly removed into prepared DEPC-treated PBS solu-
tion. After washing two times with DEPC-treated PBS
buffer, half of the femoral head was immediately frozen
in liquid nitrogen for future PCR and western blot anal-
ysis. The rest part was placed in 10 % paraformaldehyde
solution for histological analysis.
RNA extraction and quantitative RT-PCR
The samples of femoral head tissues from liquid nitro-
gen tank were mortared into powder under a sterile con-
dition. Then they were transferred to 1.5 ml Eppendorf
centrifuge tubes. The total RNA of rabbit femoral head
was extracted with Trizol reagents (Invitrogen, USA).
The procedures were performed strictly according to the
manufacturer’s instructions. The primers for RT-PCR
were designed by Oligo 6.0 primer design software
(Table 1), and synthesized from Bioko synthesis (Beijing
Biotech Co., Ltd.). The real-time PCR was performed by
using SYBR Green PCR Kit according to the manufac-
turer’s instructions. The real-time PCR data was col-
lected by an ABI 7000 Prism sequence detection system
software to calculate the Ct value of all samples. The
relative quantification of the gene expression in theexperimental group and control group were calculated
by the formulation 2-ΔΔCt.
According to quantitative calculation of RT-PCR
(2-ΔΔCt), the expression of BMP-2 mRNA in the normal
group at each time point was set up as 1, where ΔΔCt =
ΔCt1-ΔCt2, ΔCt1 is a Ct value of the housekeeping gene
GAPDH, ΔCt2 indicated the Ct value of the target gene.
The level of BMP-2 and PPAR -γ mRNA expression in
lateral femoral head (with or without decompression)
from the normal group and operation group in the real-
time RT-PCR results below was calculated by the
method described above. The results were presented by
group as X± SD (n= 5).
Western blot analysis
Proteins from rabbit femoral head tissues were isolated
with RIPA lysis buffer. Total 60 μg proteins were loaded
for electrophoresis on SDS-polyacrylamide gel. Then,
the proteins were transferred to PVDF membranes.
Rabbit anti-PPAR-γ and anti-BMP-2 (Boster Biological
Engineering Co., Ltd) antibodies were diluted at a
concentration of 1:500. The working concentration of
internal control GAPDH antibody was 1:5000. The anti-
bodies were incubated at 4 °C for overnight. Secondary
antibody horseradish peroxidase labeled goat anti-rabbit
IgG was diluted at 1:500, and incubated at room
temperature for 2 h. The protein bands were visualized
by DAB staining. The rabbit SP detection kit was
purchased from Zhongshan Golden Bridge (SP29001).
The imagines were analyzed with Bio-RAD's Quantitive
one analysis software to calculate the intensity of the
bands. The ratio of the intensities of the target genes
and GAPDH bands was used to represent the level of
the target gene protein expression.
Histological analysis of bone tissue
Histological analyses were applied to assess the micro-
scopic changes in the bone tissue. Prior to hematoxylin–
eosin (H&E), all samples of bone tissues were fixed
in 10 % (volume fraction) neutral formaldehyde solution
(0. 1 mol/L, p H= 7. 4) for 3 days. Then, the specimens
were decalcified in 10 % (volume fraction) EDTA-Tris
buffer. The decalcification solution was replaced every
week until to observe the transparent surface of the
bone tissue. After decalcification was completely fin-
ished, the resultant samples were embedded by paraffin
wax, and 5 μm sections were prepared. Sections were
routinely stained with H&E and analysed with a micro-
scope at various magnifications.
Statistical analysis
All quantitative data were expressed as mean and stand-
ard error (X ± SD). Student’s t-test was used to examine
the significance of the difference of the data between the
Table 1 Primer sequences of BMP-2, PPAR-γ and GAPDH for RT-PCR
Gene Primer sequences Length(bp) of product Tm(°C) Nucleotide number
BMP2 5' CGA AAC ACA AAC AGC GGA AAC 3' 97 84.2 AF041421
5' GCC ACA ATC CAG TCG TTC CA 3'
PPARγ 5' AGT CGC CAT CCG CAT CTT 3' 147 86.8 AF013266
5' ATC TCA TGG ACG CCG TAC TTG 3'
GAPDH 5' TGA CAA CGA ATT TGG CTA CAG 3' 83 83.6 L23961
5' GGT GGT TTG AGG GCT CTT ACT 3'
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Source of funding
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tific and Technological Project in Shaanxi Province, and
49th China Postdoctoral Science Fund. These funding
sources did not play a role in this study.
Results
The survive rate of animals
Five animals from the experimental group (total 40 rab-
bits) died during the generating the rabbit femoral head
osteonecrosis model (two of which died the day after the
second injection of horse serum). Two weeks after the
final hormone injection, total 15 of 35 survived animals
displayed early MRI features of bilateral femoral head
osteonecrosis, which were recruited into the surgical
group. All those15 animals remained live after the lateral
core decompression operation. All 6 animals from the
normal group examined by MRI showed normal bilateral
femoral head.
The expression of BMP-2 mRNA in local osteonecrosis
of femoral head
The local expression of BMP-2 in femoral head marrow
tissue in both normal control and experimental groups
was first examined by real-time PCR at each time point
after decompression operation (2, 4 and 8 weeks of post-
operation). As the results were shown in the Table 2,
the levels of BMP-2 mRNA expression in the steroid-
induced femoral head osteonecrosis with or without
lateral decompression were clearly lower than that in
normal group. The difference of BMP-2 mRNA expres-
sion between the experimental and normal groups wasTable 2 BMP-2 mRNA expression in the femoral head
(X ±SD, n = 5)
Time point Without decompresssion With decompression
2 weeks 0.326± 0.012 0.334± 0.032
4 weeks 0.131± 0.022 0.142± 0.021
8 weeks 0.125± 0.014 0.114± 0.011statistically significant (P < 0.05). In the experimental
group, BMP-2 mRNA expression in femoral head osteo-
necrosis both with and without lateral decompression
showed a decreasing trend with the increased time
of post-operation. However, there was no significant dif-
ference of the BMP-2 mRNA expression between the
femoral head osteonecrosis with and without lateral
decompression, suggesting that the lateral decompression
did not affect the local expression of BMP-2 in the fem-
oral head osteonecrosis at the mRNA level (Figure 1A).
The expression of BMP-2 protein in local osteonecrosis
of femoral head
The expression pattern of BMP-2 in femoral head from
normal and experimental groups was further confirmed
by the western blot at each time point of post-operation
(2, 4 and 8 weeks). As can be seen in the Figure 1A
and B, there was dramatically less expression of BMP-2
protein of femoral head tissue both in the steroid-
induced osteonecrosis with and without lateral decom-
pression than that in the normal control animals by
western blot. In the normal group animals, BMP-2 pro-
tein expression in the femoral head tissue did not exhibit
much significant difference as the post-operation time
increased. In contrast, in the experimental group, the
expression of BMP-2 protein in the steroid-induced fem-
oral head osteonecrosis with and without lateral decom-
pression both showed a progressively decreasing trend
with the increased post-operation time. However, there
was no significant difference of BMP-2 protein expres-
sion between femoral head osteonecrosis with and with-
out lateral decompression, suggesting that the core
decompression surgery didn’t impact the local expres-
sion of BMP-2 in the femoral head osteonecrosis at the
protein level (Figure 1B).
The expression of PPAR-γ mRNA in local femoral
head osteonecrosis
The expression of PPAR-γ mRNA in local femoral head
was also detected by real-time RT-PCR in both normal
and experimental groups at different time points of
post-operation. As the results were shown in the Table 3,
the expression levels of PPAR-γ mRNA both in the
steroid-induced femoral head osteonecrosis with and
Figure 1 BMP-2 protein expression in the femoral head tissue
by western blot analysis. (A) Western blot showed the expression
levels of BMP-2 protein in the femoral head bone tissues in the
normal control animals and experimental animals with or without
decompression at each 2, 4 and 8 week time point; (B) Western blot
results of BMP-2 expression in the femoral head was indicated by
the ratio of band intensity of BMP-2 with GAPDH.
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that in the control animals at all three time points of
post-operation (P < 0.05). And both the expression levels
of PPAR-γ mRNA in the steroid-induced femoral head
osteonecrosis with and without decompression were
increasing with the time of post-operation. However,Table 3 PPAR-γ mRNA expression in the femoral head
(X ±SD, n = 5)
Time Without decompression With decompression
2 weeks 1.258± 0.032 1.245± 0.042
4 weeks 1.432± 0.041 1.710± 0.051
8 weeks 2.013± 0.024 1.978± 0.046there was no significant difference of the expression
levels of PPAR-γ mRNA between the femoral head
osteonecrosis with and without decompression, suggest-
ing that the core decompression surgery didn’t have
effect on the expression of PPAR-γ in femoral head
osteonecrosis at the mRNA level (Figure 2A).
The expression of PPAR-γ protein in local femoral
head osteonecrosis
We further confirmed the expression pattern of PPAR-γ
in femoral head from normal and experimental groups
by western blot at different time points of post-
operation. As you can see in the Figure 2A and B, there
was dramatically higher expression of PPAR-γ protein in
femoral heads both in the steroid-induced osteonecrosis
with or without lateral decompression than that in theFigure 2 PPAR-γ protein expression in the femoral head tissue
by western blot analysis. (A) Western blot showed the expression
levels of PPAR-γ protein in the femoral head bone tissues in the
normal control animals and experimental animals with or without
decompression at each 2, 4 and 8 week time point; (B) Western blot
results of PPAR-γ expression in the femoral head was indicated by
the ratio of band intensity of PPAR-γ with GAPDH.
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expression in the femoral head slightly increased with
the increased post-operation time, but not significantly.
In contrast, the expression of PPAR-γ protein in the
steroid-induced femoral head osteonecrosis with and
without lateral decompression both showed a signifi-
cantly increased trend with the increased post-operation
time. However, there was no significant difference of
PPAR-γ protein expression between the femoral head
osteonecrosis with and without lateral decompression at
each time point of post-operation, suggesting that the
decompression surgery didn’t affect the expression of
PPAR-γ in the local femoral head osteonecrosis at the
protein level (Figure 2B).
The bone regeneration in the early treatment of the
steroid-induced femoral head osteonecrosis
We next investigated how the core decompression
surgery affected the bone regeneration in the early treat-
ment of rabbit femoral head osteonecrosis by comparing
the histopathological changes of femoral head marrow
tissue with or without decompression to the normal
control animals at each time point of post-operation.
In the normal control group, trabecular bone was con-
tinuing to exist normally at 2, 4 and 8 weeks of post-
operation, intramedullary cells were normal, and no
empty lacunae cells were observed. However, in the
experimental group without lateral decompression, the
pathogenesis of the femoral head osteonecrosis was con-
tinuing to proceed at all time points of post-operation.
The trabecular bone fractures were observed and the
architecture of marrow tissue was disordered. At 8 weeks
of post-operation, a large number of bone marrow cell
necrosis was observed and the normal bone marrow
architecture was completely disappeared. In the experi-
mental animals with decompression, decompression
tunnel was seen in the femoral head osteonecrosis. In
contrast, a large number of proliferative fibroblast cells
were seen surrounding and filling the decompression
canal at 2 weeks of post-operation. A small amount of
new capillaries and ossification center started to be vis-
ible around the decompression tunnel at 4 weeks of
post-operation. At 8 weeks after surgery, decompression
animals showed disordered new trabecular bone and a
large number of osteoblasts surrounding the decompres-
sion tunnel, but there still existed the phenomenon of
trabecular bone fractures and marrow cell necrosis
(Figure 3).
Discussion
Recent studies have shown that glucocorticoid can acti-
vate the proteins of promoting the binding of fat
transcription factors with enhancers (C/EBPδ, CCAAT/
enhancer-binding proteins). C/EBPδ protein can specificallybind to the locus of PPAR-γ promoter and stimulate the
expression of PPAR-γ gene. This would promote bone
marrow stromal cells to differentiate into fat cells [12],
which eventually results in the fat accumulation in the
bone marrow. Yang et al. has shown that the biological
effects of endogenous BMP-2 were stronger than those
of purified recombinant BMP-2[13]. The BMP-2 protein
generally stimulates the proliferation and differentiation
of local raw bone precursor cells in autocrine and para-
crine manners. And it forms a positive feedback mechan-
ism to regulate cellular activities, which accelerates bone
formation and bone repair. By in vivo and in vitro stud-
ies, Kugimiya et al. found that endogenous BMP-2 and
BMP-6 cooperatively play pivotal roles in bone formation
under both physiological and pathological conditions
through a way of endochondral osteogenesis rather than
intramembranous osteogenesis [14]. Kloen et al. also
studied the local expression of BMP-2, BMP-4, and
BMP-7 in twenty-one patients with a delayed union or a
nonunion fracture by immunohistochemical analysis
[15]. Their results showed that endogenous BMPs were
continuing to present during the process of the bone
regeneration and play important roles in bone repair.
However, many studies have demonstrated that the local
expression of endogenous BMP-2 in femoral head tissue
was inhibited in the steroid-induced osteonecrosis of
femoral head (GONFH), which leaded to significantly
reduced functions of the MSCs in lesions, bone repair
and reconstruction capacity, lack of timely repair of bone
necrosis, and subchondral bone burden and mechanical
dysfunction, and eventually contribute to in the femoral
head collapse. Our previous studies also obtained similar
results [16]. At the time that GONFH was induced,
BMP-2 mRNA expression was significantly reduced
compared to that in normal animals. The expression
levels of BMP-2 mRNA at 2, 4 and 8 weeks post-
operation were 0.326, 0.131 and 0.125 times less than
that in the normal BMP-2 mRNA expression level at
each time point above, respectively. In the experimental
animals, BMP-2 mRNA expression showed a decreasing
trend with the increased time. BMP-2 protein expression
in the experimental group also exhibited the same
pattern as BMP-2 mRNA in comparison with the normal
control animals. By immunohistochemical staining with
anti-BMP-2 antibody, BMP-2 was observed weak expres-
sion in bone cells in experimental group animals at two
week time point. And BMP-2 immunostaining started to
be negative at 4 week time point. In contrast, PPAR-γ
mRNA was overexpressed in the femoral head in
GONFH. The expression levels of PPAR-γ mRNA in the
femoral medullary cavity of the experimental animals at
2, 4 and 8 week time points were 1.258, 1.432 and 2.013
times higher than that in the normal group at each time
point, respectively, and progressively increased as the
Figure 3 Histological analysis of the femoral head in normal control and experimental groups with or without core decompression at
different post-operation time points.
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expression in each time point was much higher than that
the normal control group. In the normal control animals,
it was noted that the expression levels of PPAR-γ protein
were also slowly increasing with time growth. This is
probably due to the physiologically accumulated fat
replacement of bone marrow in the aged rabbits. Our
immunohistochemistical data further confirmed that
PPAR-γ expression was mainly located in the medullary
cavity of the bone marrow. PPAR-γ staining in the fem-
oral head marrow of experimental animals progressively
increased to be strongly positive as the post-operation
time up to 8 weeks. Therefore, the overexpression of
PPAR-γ in the cells of marrow cavity in GONFH
enhanced the MSCs to differentiate into fat cells, which
accordingly reduce the bone cell differentiation. This
contributes to a series of pathological reactions such as
the fat replacement of bone marrow, the intramedullary
hyperpressure, dysfunction of local microcirculation,
fat cell hypertrophy and hyperplasia, localized fat throm-
bosis, lack of bone regeneration, and the reduction of
the number and activity of osteoblast cells [17,18]. This
eventually leads to the femoral head necrosis, which
is one of the crucial reasons for the development
of GONFH.Conclusions
In summary, long-term or heavy use of steroids led to
over expression of PPAR-γ in the femoral head. This con-
tributed to generation of a large number of fat cells in the
bone marrow, fat replacement of bone marrow, the intra-
medullary hyperpressure, dysfunction of the local micro-
circulation, insufficient differentiation of bone cells, and
reduction of the number and activities of osteoblasts
[19]. Meanwhile, BMP-2 expression was inhibited, which
would reduce the activities of local MSCs, and capacity
of bone repair and reconstruction. Both pathological
changes, on the one hand, were caused by a large number
of bone cell degeneration and necrosis, and insufficient
bone regeneration. On the other hand, the obstruction of
reconstruction of bone tissue and slow down of bone re-
pair eventually leaded to the osteonecrosis of femoral
head, which is a major cause of morbidity of hip collapse.
The core decompression surgery is selected for the
early treatment of femoral head osteonecrosis due to the
simplicity of its procedure, an easy to perform operation,
and less patient injury, which is easy to be acceptable for
patients. Moreover, there were studies reported that the
bone marrow drilling core decompression had better
effects for patients with Ficat stage 0 and 1, can prevent
the femoral head collapse [20]. However, mixed results
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osteoncerosis were also reported [21,22].
Some studies even believed that core decompression
was not able to improve the process of osteonecrosis.
This phenomenon may be closely associated with causes
which lead to femoral head necrosis. Particularly like
steroid-induced osteonecrosis of femoral head, core
decompression appears to be able to reduce the intrame-
dullary pressure, improve intramedullary microcircula-
tion, and temporarily ease the process of osteonecrosis.
However, the risk factors that lead to the pathological
processes of bone necrosis such as the formation of
increased intramedullary pressure, dysfunction of angio-
genesis in the femoral head necrosis lesion, declined
capacity of bone repair and regeneration, and increased
activity of osteoclast still exist. The core decompression
operation alone did not directly address these series of
pathological changes, because the osteonecrosis caused
by application of glucocorticoids is due to the outcome
of interactions between factors such as primary diseases,
drugs, organ's metabolism and endocrine. In fact,
GONFH is one of the side effects produced by the drug
treatments which result in the metabolic and endocrine
disorders in bone tissue. Thus, the effect of relying on
single core decompression operation to regulate the
endocrine and bone metabolism may be limited. The
current studies displayed that sole decompression oper-
ation did not reverse the process of the steroid-induced
osteonecrosis of femoral head, and not alter the patho-
logical changes caused by the local decreased BMP-2
and progressively increased PPAR-γ expression. More-
over, later stage pathological examination revealed that
the intramedullary bone tissue in the femoral head with
lateral decompression was, despite noted the bone
repair, but still visible of trabecular bone fractures and
necrosis of bone marrow cells eight weeks later post-
operation. The long-term effect of decompression in the
bone regeneration of steroid-induced osteonecrosis is
not ideal. Therefore, the basic core decompression oper-
ation in combination with other treatments like active
biological molecules or local application of drugs may
be able to achieve the goals of decreasing the pressure
of local bone lesions as well as improving or even revers-
ing the organism's metabolic and endocrine disorders
[23,24,25]. Taken together, core depression surgery in
combination with other local application of drugs is
worth to be further investigated for the early and effective
treatments of steroid-induced femoral head osteonecrosis.
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